Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University.
Department of Clinical Epidemiology, Hyogo College of Medicine.
Circ J. 2020 Feb 25;84(3):471-478. doi: 10.1253/circj.CJ-19-0980. Epub 2020 Jan 29.
The effect of diabetes mellitus (DM) status on the long-term risk for heart failure (HF) in patients undergoing coronary revascularization has not been adequately evaluated.
In this study, 15,231 patients who underwent coronary revascularization in the CREDO-Kyoto Registry Cohort-2 were divided into 2 groups according to DM status (DM group: n=5,999; Non-DM group: n=9,232). The DM group was further divided into 2 groups according to insulin treatment (insulin-treated DM [ITDM]: n=1,353; non-insulin-treated DM [NITDM]: n=4,646). The primary outcome measure was HF hospitalization. The cumulative 5-year incidence of HF hospitalization was significantly higher in the DM than non-DM group (11.0% vs. 6.6%, respectively; log-rank P<0.0001), and in the ITDM than NITDM group (14.6% vs. 10.0%, respectively; log-rank P<0.0001). After adjusting for confounders, the increased risk of HF hospitalization with DM relative to non-DM remained significant (hazard ratio [HR] 1.47, 95% confidence interval [CI] 1.30-1.67, P<0.0001), whereas the risk associated with ITDM relative to NITDM was not significant (HR 1.17, 95% CI 0.96-1.43, P=0.12).
The adjusted long-term risk for HF hospitalization after coronary revascularization was significantly higher in DM than non-DM patients, regardless of revascularization strategy, but did not differ between ITDM and NITDM patients.
糖尿病(DM)状态对接受冠状动脉血运重建的患者心力衰竭(HF)的长期风险的影响尚未得到充分评估。
在这项研究中,根据 DM 状态(DM 组:n=5999;非 DM 组:n=9232)将在 CREDO-Kyoto 注册队列-2 中接受冠状动脉血运重建的 15231 名患者分为 2 组。DM 组进一步根据胰岛素治疗情况分为 2 组(胰岛素治疗 DM [ITDM]:n=1353;非胰岛素治疗 DM [NITDM]:n=4646)。主要观察终点为 HF 住院。DM 组的 5 年累积 HF 住院发生率明显高于非 DM 组(分别为 11.0%和 6.6%;log-rank P<0.0001),ITDM 组明显高于 NITDM 组(分别为 14.6%和 10.0%;log-rank P<0.0001)。调整混杂因素后,DM 组 HF 住院风险较非 DM 组仍显著增加(HR 1.47,95%CI 1.30-1.67,P<0.0001),而 ITDM 组与 NITDM 组的风险差异无统计学意义(HR 1.17,95%CI 0.96-1.43,P=0.12)。
无论血运重建策略如何,与非 DM 患者相比,DM 患者冠状动脉血运重建后 HF 住院的调整后长期风险明显更高,但 ITDM 患者与 NITDM 患者之间的风险无差异。